Biosimilars | Association for Accessible Medicines
ICYMI - View memorable moments and quotes from #Access2021



Please see below for shareable resources, press releases and other content relating to this issue. You can also use the search bar in the header of our website to search for specific keywords across all content on the site.

PDFJul 18, 2018Tony Kurilla
AAM Statement on FDA’s Biosimilars Action Plan
Download |
PDFApr 24, 2018Erica Klinger
AAM Biosimilars Council Policy Recommendations Biosimilars
Download |
Press Release Feb 24, 2020 Rachel Schwartz
AAM and the Biosimilars Council Applaud FDA’s Release of Enhanced Purple Book
Press Release Dec 19, 2019 Rachel Schwartz
USMCA Sets a New Standard for Lowering Drug Prices and Expanding Access to Medicines
Press Release Dec 10, 2019 Rachel Schwartz
USMCA Trade Agreement: A Victory for America’s Patients
Press Release Mar 7, 2019 Rachel Schwartz
AAM Statement on FDA Draft Guidance on Biosimilar Naming Requirements

Association for Accessible Medicines


Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.